Incyte (INCY) Current Deferred Tax Assets (2013 - 2015)
Incyte (INCY) posted Current Deferred Tax Assets of $9.7 million for Q3 2015, up 25.72% on a QoQ basis from $7.7 million in Q2 2015, and up 1153.16% year-over-year from $775000.0 in Q3 2014.
Incyte (INCY) Current Deferred Tax Assets (2013 - 2015) Analysis & Trends
Incyte's Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $9.7 million for Q3 2015.
- Quarterly Current Deferred Tax Assets rose 1153.16% year-over-year to $9.7 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $9.7 million (up 1153.16% YoY) and the FY2014 annual result came in at $19.6 million, up 2094.53% from the prior year.
- Current Deferred Tax Assets was $9.7 million for Q3 2015 at Incyte, up from $7.7 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $19.6 million in Q4 2014 and bottomed at $775000.0 in Q3 2014.
- A 3-year average of $5.8 million and a median of $3.5 million in 2014 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2014 — Current Deferred Tax Assets surged 2094.53% — and 2015, when it jumped 575.45%.
- Incyte's Current Deferred Tax Assets stood at $895000.0 in 2013, then jumped by 2094.53% to $19.6 million in 2014, then tumbled by 50.55% to $9.7 million in 2015.
- Business Quant data shows INCY's Current Deferred Tax Assets at $9.7 million in Q3 2015, $7.7 million in Q2 2015, and $6.0 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 9.71 Mn |
| Sep 30, 2015 | 9.71 Mn |
| Jun 30, 2015 | 7.73 Mn |
| Jun 30, 2015 | 7.73 Mn |
| Mar 31, 2015 | 6.03 Mn |
| Mar 31, 2015 | 6.03 Mn |
| Dec 31, 2014 | 19.64 Mn |
| Dec 31, 2014 | 19.64 Mn |
| Sep 30, 2014 | 775,000.00 |
| Sep 30, 2014 | 775,000.00 |
| Jun 30, 2014 | 900,000.00 |
| Jun 30, 2014 | 900,000.00 |
| Mar 31, 2014 | 892,000.00 |
| Mar 31, 2014 | 892,000.00 |
| Dec 31, 2013 | 895,000.00 |
| Dec 31, 2013 | 895,000.00 |